Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.

about

Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.

Item

http://www.wikidata.org/entity/Q55471442

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Development and testing of AAV ...... ment of methamphetamine abuse.

@en

Development and testing of AAV ...... ment of methamphetamine abuse.

@nl

type

Item

label

Development and testing of AAV ...... ment of methamphetamine abuse.

@en

Development and testing of AAV ...... ment of methamphetamine abuse.

@nl

prefLabel

Development and testing of AAV ...... ment of methamphetamine abuse.

@en

Development and testing of AAV ...... ment of methamphetamine abuse.

@nl

P1476

Development and testing of AAV ...... ment of methamphetamine abuse.

@en

P2093

Chris T Bolden

http://www.w3.org/2001/XMLSchema#string

E Elizabeth Reichard

http://www.w3.org/2001/XMLSchema#string

Eric C Peterson

http://www.w3.org/2001/XMLSchema#string

Guillermo A Gonzalez

http://www.w3.org/2001/XMLSchema#string

Laura E Ewing

http://www.w3.org/2001/XMLSchema#string

Michael D Hambuchen

http://www.w3.org/2001/XMLSchema#string

Nisha Nanaware-Kharade

http://www.w3.org/2001/XMLSchema#string

Paris Margaritis

http://www.w3.org/2001/XMLSchema#string

S Michael Owens

http://www.w3.org/2001/XMLSchema#string

Sinthia Alam

http://www.w3.org/2001/XMLSchema#string

P2860

Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering

Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites

Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy.

AAV-mediated liver-directed gene therapy.

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

Gene therapy using adeno-associated virus vectors

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B

P304

e0200060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0200060

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Charles E Hay

P577

2018-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29958300

http://www.w3.org/2001/XMLSchema#string

P932

6025879

http://www.w3.org/2001/XMLSchema#string